Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Pedley

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
International Journal of Radiation Biology|May 22, 2002
Antibody and radionuclide characteristics and the enhancement of the effectiveness of radioimmunotherapy by selective dose delivery to radiosensitive areas of tumourA A Flynn, R B Pedley, A J Green, et al.
British Journal of Cancer|November 21, 1998
Clearance of yttrium-90-labelled anti-tumour antibodies with antibodies raised against the 12N4 DOTA macrocycleJ L Casey, D J King, R B Pedley, et al.
British Journal of Cancer|February 1, 1990
Preliminary observations on the microdistribution of labelled antibodies in human colonic adenocarcinoma xenografts: relevance to microdosimetryR B Pedley, G M Boxer, J A Boden, et al.
International Journal of Cancer|May 16, 1995
A single chain Fv derived from a filamentous phage library has distinct tumor targeting advantages over one derived from a hybridomaM J Verhaar, K A Chester, P A Keep, et al.
International Journal of Cancer|April 1, 1994
Production and tumour-binding characterization of a chimeric anti-CEA Fab expressed in Escherichia coliK A Chester, L Robson, P A Keep, et al.
British Journal of Cancer|November 1, 1996
Preparation, characterisation and tumour targeting of cross-linked divalent and trivalent anti-tumour Fab' fragmentsJ L Casey, D J King, L C Chaplin, et al.
British Journal of Cancer|March 1, 1986
The potential of carboxypeptidase G2-antibody conjugates as anti-tumour agents. I. Preparation of antihuman chorionic gonadotrophin-carboxypeptidase G2 and cytotoxicity of the conjugate against JAR choriocarcinoma cells in vitroF Searle, C Bier, R G Buckley, et al.
Cancer Research|June 19, 2001
Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin a-4 3-O-phosphateR B Pedley, S A Hill, G M Boxer, et al.
Lancet (London, England)|February 19, 1994
Phage libraries for generation of clinically useful antibodiesK A Chester, R H Begent, L Robson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 19, 2004
Radiolabelling of glycosylated MFE-23::CPG2 fusion protein (MFECP1) with 99mTc for quantitation of tumour antibody-enzyme localisation in antibody-directed enzyme pro-drug therapy (ADEPT)R J Francis, S J Mather, K Chester, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
International Journal of Radiation Biology|May 22, 2002
Antibody and radionuclide characteristics and the enhancement of the effectiveness of radioimmunotherapy by selective dose delivery to radiosensitive areas of tumourA A Flynn, R B Pedley, A J Green, et al.
British Journal of Cancer|November 21, 1998
Clearance of yttrium-90-labelled anti-tumour antibodies with antibodies raised against the 12N4 DOTA macrocycleJ L Casey, D J King, R B Pedley, et al.
British Journal of Cancer|February 1, 1990
Preliminary observations on the microdistribution of labelled antibodies in human colonic adenocarcinoma xenografts: relevance to microdosimetryR B Pedley, G M Boxer, J A Boden, et al.
International Journal of Cancer|May 16, 1995
A single chain Fv derived from a filamentous phage library has distinct tumor targeting advantages over one derived from a hybridomaM J Verhaar, K A Chester, P A Keep, et al.
International Journal of Cancer|April 1, 1994
Production and tumour-binding characterization of a chimeric anti-CEA Fab expressed in Escherichia coliK A Chester, L Robson, P A Keep, et al.
British Journal of Cancer|November 1, 1996
Preparation, characterisation and tumour targeting of cross-linked divalent and trivalent anti-tumour Fab' fragmentsJ L Casey, D J King, L C Chaplin, et al.
British Journal of Cancer|March 1, 1986
The potential of carboxypeptidase G2-antibody conjugates as anti-tumour agents. I. Preparation of antihuman chorionic gonadotrophin-carboxypeptidase G2 and cytotoxicity of the conjugate against JAR choriocarcinoma cells in vitroF Searle, C Bier, R G Buckley, et al.
Cancer Research|June 19, 2001
Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin a-4 3-O-phosphateR B Pedley, S A Hill, G M Boxer, et al.
Lancet (London, England)|February 19, 1994
Phage libraries for generation of clinically useful antibodiesK A Chester, R H Begent, L Robson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 19, 2004
Radiolabelling of glycosylated MFE-23::CPG2 fusion protein (MFECP1) with 99mTc for quantitation of tumour antibody-enzyme localisation in antibody-directed enzyme pro-drug therapy (ADEPT)R J Francis, S J Mather, K Chester, et al.
Pageof 8